Does the Treatment of Proton Pump Inhibitors Reduce Dysplasia or Adenocarcinoma Development in Barrett's Esophagus?

Turkish Journal of Gastroenterology - Turkey
doi 10.5152/tjg.2017.09
Full Text
Abstract

Available in full text

Date
Authors
Publisher

AVES Publishing Co.

Related search

Proton Pump Inhibitors Display Antitumor Effects in Barrett's Adenocarcinoma Cells

Frontiers in Pharmacology
Pharmacology
2016English

Treatment of Barrett's Esophagus With High-Grade Dysplasia or Cancer: Predictors of Surgical Versus Endoscopic Therapy

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2008English

MicroRNAs in Barrett's Esophagus and Esophageal Adenocarcinoma

Current Opinion in Pharmacology
Drug DiscoveryPharmacology
2009English

Affinity Peptide for Targeted Detection of Dysplasia in Barrett's Esophagus

Gastroenterology
HepatologyGastroenterology
2010English

MicroRNA-196a Is a Potential Marker of Progression During Barrett's Metaplasia-Dysplasia-Invasive Adenocarcinoma Sequence in Esophagus

American Journal of Pathology
Forensic MedicinePathology
2009English

Proton-Pump Inhibitors for the Treatment of Functional Dyspepsia

Therapeutic Advances in Gastroenterology
Gastroenterology
2011English

Patient Preferences for the Chemoprevention of Esophageal Adenocarcinoma in Barrett's Esophagus

American Journal of Gastroenterology
HepatologyGastroenterology
2008English

Proton Pump Inhibitors for the Treatment of Cancer in Companion Animals

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2015English

Endoscopic Submucosal Dissection of a Minute Intramucosal Adenocarcinoma in Barrett's Esophagus

Digestive Endoscopy
Nuclear MedicineRadiologyImagingGastroenterology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy